Caseous Calcification of the Mitral Annulus Leading to Symptomatic Mitral Stenosis

Abstract

Caseous calcification of the mitral annu-lus (CCMA) is a rare variant of mitral annular calcification, which can be difficult to diagnose and can be misdiag-nosed as a cardiac tumour or abscess. Multimodality imaging is important for the diagnosis of this entity and to avoid unnecessary surgical treatment. We present the case of a 77-year-old female patient with initially asymp-tomatic CCMA who later developed third degree atrioven-tricular heart block. Four years after the initial diagnosis, she was admitted to hospital for acute heart failure due to mitral stenosis. Multimodality imaging including transthoracic and transoesophageal echocardiography, and computed tomography showed an increase in the size of the caseous calcification with symptomatic mitral stenosis.

Introduction

Caseous calcification of the mitral annulus is a rare finding [1,2]. It is commonly misdiagnosed as an abscess or a tumour of the mitral valve annulus [1]. As it is a benign process, an accurate diagnosis is important to avoid erroneous management and potentially unnecessary surgery in asymptomatic patients.

Case report

A 77-year-old female patient presented to the emergency department with several days of worsening dyspnoea. Her past medical history was significant for hypertension, dyslipidaemia, obesity, type II diabetes, cognitive impairment and mobility difficulties due to a polyradiculopathy.

A routine transthoracic echocardiogram (TTE) performed 4 years previously, with a view to orthopaedic surgery, had revealed a cardiac mass attached to the posterior mitral annulus with a mitral mean gradient of 6 mm Hg (at a heart rate of 80 beats per minute). At that time cardiac magnetic resonance imaging (cMRI) and computed tomography (CT) were performed and the diagnosis of caseous calcification of the mitral annulus was established (Figure 1). Two years after the initial diagnosis, the patient developed third degree atrioventricular block for which a dual-chamber pacemaker was implanted. The patient was asymptomatic for a further 2 years until she developed an episode of acute severe dyspnoea.

In the emergency department the patient’s vital signs (oxygen saturation 88%), clinical examination (tachypnoea, orthopnoea, bilateral lung crackles), laboratory tests (elevated N-terminal pro-B-type natriuretic peptide [NT-proBNP]) and chest X-ray (lung congestion) confirmed the diagnosis of acute heart failure, albeit of unclear aetiology: her blood pressure was only mildly increased, mild troponin elevation argued against an acute coronary syndrome, haemoglobin levels and heart rate were stable (

Table 1. Principal clinical and biological values which could contribute to the acute heart failure or which may affect echocardiographic measures, showing no changes overtime.

	First TTE, February 2016	Acute heart failure, ER, 21 July 2020	Second TTE, 23 July 2020	TOE, October 2020
Haemoglobin (g/l)	114	103	109	134
NT-pro-BNP (ng/l)	347	600	/	/
Heat rate (bpm)	70	75	70	85
Blood pressure (mm Hg)	160/90	137/100	105/54	140/70

). The patient was admitted for oxygen supplementation and intravenous diuretics with rapid recovery ensuing in a few days. A TTE documented normal heart function but an increase in the size of the cardiac mass ( 46 mm × 31 mm compared with 36 mm × 27 mm 4 years before), the mean gradient across the mitral valve was unchanged at 6–7 mm Hg at a heart rate of 65 bpm (Figure 2) The mitral valve area obtained by two-dimensional planimetry from the parasternal short axis view was 1.2 cm² (Figure 3B). No other significant valve disease was found. Transoesophageal echocardiography (TOE) showed moderate mitral stenosis. The mitral valve orifice measured by three-dimensional planimetry was 1.4 cm² (Figure 3A). Remarkably, there was an increase in the mean diastolic mitral gradient from 6 mm Hg at the time of the TTE to 13 mm Hg on TOE, probably due to a higher heart rate of 85 bpm (Figure 5). A CT scan showed an increased size of the mass (Figure 4). Due to the frailty of the patient and in accordance with her wish not to undergo any invasive treatment, surgery was not proposed. The patient was discharged before being admitted 2 months later for another episode of acute heart failure treated with intravenous diuretics. The therapeutic attitude was altered and at this time the patient was again discharged for ambulatory follow up for treatment adjustment and only symptomatic management if acute heart failure happens again.

Discussion

• Pathogenesis and prevalence

Mitral annular calcification is a relatively common degenerative condition of the mitral valve, usually involving the posterior annulus, in some series affecting 8.5% of the general population [2].

Caseous calcification of the mitral annulus is a rare variant of mitral annular calcificationand occurs when there is liquefaction and caseous degeneration (caseous typically refers to a category of necrosis, which is encountered in tuberculosis) of the calcified annulus, but the exact mechanism is unknown [1]. It tends to occur more often in elderly women and is associated with hypertension and patients with chronic renal failure or altered calcium-phosphate metabolism [3,5]. Macroscopically, caseous calcification of the mitral annulus appears like a calcified envelope that surrounds caseous materiel inside (described as a toothpaste-like, milky, material) [1]. This contrasts with classical mitral annular calcification, which usually lacks central hypoechoic area, tends to be less rounded in shape and extend to a greater portion of the posterior mitral annulus. Less frequently, the differential diagnosis includes radiation-induced mitral annulus calcification (usually involving the aorto-mitral curtain) or, rarely, cardiac tumours. The true prevalence of caseous calcification of the mitral annulus is unknown. Based on several series it may vary between 0.63 and 0.64% of the 10.6% of patients with MAC found on echocardiography [3,4]. A higher prevalence of casesous calcification of 2.7% was found in a necropsy series of mitral annular calcification[1].

Clinical manifestation

The most common symptoms are palpitations and dyspnoea, but rarely patients may present syncope secondary to atrioventricular blocks, as did our patient. This is possibly due to direct extension of calcific deposits to the area of the atrioventricular node and the bundle of His. Less often, systemic embolisation can occur [1,3,6,11]. Moreover, the presence of mitral annular calcification is associated with increased cardiovascular events and mortality, as well as with significant obstructive coronary artery disease. Possible reasons for these results are that mitral annular calcification may be a marker for atherosclerotic disease burden, or that other unmeasured influences, such as metabolic, inflammatory and haemostatic risk factors, might be responsible for the increased risk of cardiovascular disease and mortality in these patients [11].

Multimodal imaging

On transthoracic echocardiography (TEE), appears as a round calcification, with well-defined brightened edges corresponding to an echodense periphery, and a central echolucent area corresponding to the central liquefaction area. Colour Doppler shows a lack of flow inside the central zone [1,7]. Differences between mitral annular calcification and caseous calcification on TEE are summarised on

Table 2. Differences between mitral annular calcification (MAC) and caseous calcification of the mitral annulus (CCMA) on transthoracic echocardiography.

	MAC	CCMA
Echocardiographic characteristics	– Echo-dense shelf-like structure (semilunar disc on parasternal short axis view)	– Round calcification
	– Irregular appearance	– Well-defined brightened edges corresponding to an echodense periphery
	– Mid-basis of posterior leaflet	– Central echolucent area corresponding to the central liquefaction area
	– Associated with acoustic shadowing	– Posterior annular region

and illustrated in Figure 6.

Transoesophageal echography (TOE) can be performed to better characterise the mass in patients with poor echographic windows, to better quantify mitral regurgitation, if present, and better delineate its anatomic boundaries

On CT scan, appears as a well-defined oval or crescentshaped hyperdense mass with peripheral calcification, with high Hounsfield units and lack of contrast enhancement [1,7,8].

Cardiac MRI may be helpful in equivocal cases. CCMA is seen as a hypointense zone both in T1- and T2-weighted sequences. In postcontrast studies, contrast enhancement on first-pass sequences is not found; however, there may be peripheral enhancement during delayed postcontrast sequences [7,9,10].

Treatment

Caseous calcification of the mitral annulus is considered as a benign tumour and conservative medical treatment (follow up, diuretics) is indicated for asymptomatic patients. Surgical treatment is considered when mitral valvular dysfunction is present (regurgitation or stenosis), when embolic events occur or when it is not possible to exclude a malignant tumour with noninvasive diagnostic tools.

Conclusion

Caseous calcification of the mitral annulus is a rare benign finding, likely underreported and may be confused with tumours or abscess. Clinical manifestations vary from lack of symptoms to acute heart failure due to mitral valve dysfunction (stenosis or regurgitation) and may include syncope secondary to atrioventricular block, and stroke. Multimodality imaging is often necessary to establish the diagnosis, to decide on the best treatment and avoid often times unnecessary surgery.